TrademarkDir
GENERATE
DEAD

Serial Number

88701131

Owner

GENERATE BIOLOGICS, INC.

Attorney

Jennifer M. Mikulina

Filing Date

Nov 21, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

GENERATE Trademark

Serial Number: 88701131

GENERATE is a trademark filed by GENERATE BIOLOGICS, INC. on November 21, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

GENERATE BIOLOGICS, INC. (5 trademarks)

55 CAMBRIDGE PARKWAY, SUITE 800E
CAMBRIDGE, MA 02142

Entity Type: 03

Flagship VL56, Inc. (4 trademarks)

55 Cambridge Parkway, Suite 800E
Cambridge, MA 02142

Entity Type: 03

GENERATE BIOMEDICINES, INC. (17 trademarks)

55 CAMBRIDGE PARKWAY, SUITE 800E
CAMBRIDGE, MA 02142

Entity Type: 03

Trademark Details

Filing Date

November 21, 2019

Registration Date

Not Registered

Published for Opposition

August 18, 2020

Goods & Services

pharmaceutical preparations for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy; therapeutic agents for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders but excluding DNA-based gene therapy; therapeutic products for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy

biological and chemical agents for scientific and research use

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 15, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 15, 2025 ABN6
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 3, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 3, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 3, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 3, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 3, 2025 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 18, 2025 EXRA
SOU EXTENSION 5 GRANTED
Apr 17, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 17, 2025 AITU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 3, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 3, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 3, 2025 COAR
SOU EXTENSION 5 FILED
Jan 13, 2025 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 13, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 17, 2024 EXRA
SOU EXTENSION 4 GRANTED
Jul 17, 2024 EX4G
SOU EXTENSION 4 FILED
Jul 17, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 17, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 7, 2024 EXRA
SOU EXTENSION 3 GRANTED
Feb 5, 2024 EX3G
SOU EXTENSION 3 FILED
Feb 5, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 5, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 22, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jul 20, 2023 EX2G
SOU EXTENSION 2 FILED
Jul 20, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 20, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 24, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jan 20, 2023 EX1G
SOU EXTENSION 1 FILED
Jan 20, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 20, 2023 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 22, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 22, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 22, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 22, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 22, 2022 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 9, 2022 NOAM
TTAB RELEASE CASE TO TRADEMARKS
Jun 29, 2022 TMBN
OPPOSITION TERMINATED NO. 999999
Jun 29, 2022 OP.T
OPPOSITION DISMISSED NO. 999999
Jun 29, 2022 OP.D
OPPOSITION INSTITUTED NO. 999999
Oct 28, 2020 OP.I
POST PUBLICATION AMENDMENT - ENTERED
Oct 22, 2020 CHPB
ASSIGNED TO PETITION STAFF
Oct 16, 2020 APET
EXTENSION OF TIME TO OPPOSE RECEIVED
Sep 16, 2020 ETOF
TEAS POST PUBLICATION AMENDMENT RECEIVED
Sep 2, 2020 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 18, 2020 NPUB
PUBLISHED FOR OPPOSITION
Aug 18, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 29, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 10, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 26, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 26, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 26, 2020 TROA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 29, 2020 ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 12, 2020 ASGN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 28, 2019 GNRN
NON-FINAL ACTION E-MAILED
Dec 28, 2019 GNRT
NON-FINAL ACTION WRITTEN
Dec 28, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 27, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 27, 2019 NWOS

Related Trademarks

More from this Owner

GENERATE:BIOMEDICINES

GENERATE:BIOMEDICINES

GENERATE:BIOMEDICINES

GENERATE:BIOMEDICINES

GENERATE BIOMEDICINES

GENERATE BIOMEDICINES

GENERATE

GENERATE

CHROMA

CHROMA

CHROMA

CHROMA